2-Quinolinecarboxylic acid derivatives are relatively uncommon in nature. To date, about 20 simple quinolinecarboxylic acids have been isolated from insects, [1] [2] [3] [4] bacteria, [5] [6] [7] and plants. [8] [9] [10] Xanthurenic acid, or 4,8-dihydroxy-2-quinolinecarboxylic acid, a metabolite of tryptophan, is present in the urine of vitamin B 6 -deficient rats. 11 The 8-methoxy derivative of xanthurenic acid is a possible endogenous carcinogen. 12 Only seven quinolinecarboxylic acid derivatives have been reported from marine organisms. These include 4,5,8- trihydroxyquinolinecarboxylic acid from the Antarctic sponge Dendrilla membranosa, 13 xanthurenic acid and its derivatives, tridemnic acids A and B, that were isolated from the Canadian ascidian Trididemnum sp., 14 distomadine B, which was isolated from the New Zealand ascidian Pseudodistoma aureum, 15 and perspicamides A and B, that were purified from the Australian ascidian Botrylloides perspicuum. 16 As part of our continuing efforts to discover new chemistry from Australian ascidians, [16] [17] [18] [19] we undertook a detailed chemical analysis of the previously uninvestigated ascidian, Aplidium caelestis. These studies resulted in the isolation of four new brominated natural products, caelestines A−D (1) (2) (3) (4) . The structures of 1-4 were determined by analysis of the NMR and MS data. Compound 1 has been previously synthesized but not spectroscopically characterized. This is the first report of brominated quinolinecarboxylic acids from nature. Caelestines A−D (1-4) were tested against three mammalian cell lines (MCF-7, NFF, and MM96L) and a panel of microbial strains and only showed minor cytotoxicity. In this paper we report the isolation, structure elucidation, as well as the bioactivity of compounds 1-4.
The freeze-dried and ground ascidian A. caelestis was exhaustively extracted with n- receptor. 20 No spectroscopic data have been previously reported for 1.
Caelestine B (2) 6 and hence the structure of 3 could not be initially confirmed. This broad signal was possibly due to tautomerization between the 4-oxo-1,4-dihydroquinoline and the 4-hydroxy-quinoline moieties, which has been reported for related compounds in various solvents. 13, 19 In order to investigate whether a change of deuterated solvents could improve the shape of the H-3 signal, the 1 H NMR spectrum of 3 was recorded in CD 3 OD. This resulted in all the non-exchangeable protons appearing as sharp signals suggesting that 3 was present as one preferred tautomeric form in CD 3 OD. In a similar manner to caelestines A and B, the HMBC data was critical for the structure assignment of 3. In CD 3 OD the proton at δ upfield by 4.9, 9.2, and 5.8 ppm, respectively, compared to those in 2, since the presence of methoxy group at C-8 had shielding effects at the ortho and para positions. 21 Subsequently, two bromine atoms were placed at C-6 and C-7. Thus the structure of caelestine D (4) was assigned as 6,7-dibromo-8-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid. Table 3 shows the in vitro activity of compounds 1-4 against three mammalian cell types. MCF-7 is derived from a breast adenocarcinoma cancer, MM96L is an amelanotic metastatic melanoma cell line, and NFF (neonatal foreskin fibroblasts) is a "normal" primary cell type. The NFF cells are routinely used in toxicity studies to determine compound selectivity for cancer cells. All compounds (1-4) showed only minor activity at 100 µM. Mammalian cell assays. The experimental details of the mammalian cell assays have been described in a previous publication. 22 Doxorubicin was used as a positive control for all assays and gave 99% inhibition of MCF-7 and MM96L, and 95% inhibition of NFF at 1 µM.
Antimicrobial Assays. Antimicrobial activities were evaluated using the CLSI broth microdilution assay 23 with each compound screened in a decimal dilution series commencing from 0.1 µM to 10 mM. 
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